• Newsletters
  • Gift Membership
Logo Logo
Take Scroll With You Download the app to read our award-winning journalism on the go and stay up-to-date with our notifications.
Get the app Get the app
ANDROID iOS
  • Home
  • Common Ground
  • The India Fix
  • Eco India
  • The Latest
  • The Reel
  • Magazine
  • Video
  • Trending
    • Language and power: What Ambedkar and Periyar teach us about Maharashtra’s Hindi debate
    • For Jane Austen and her heroines, walking was more than a pastime – it was a form of resistance
    • A look at 15th-century India through the eyes of a Genoan merchant
    • How the uncivility in India’s gated communities is the result of deliberate political design
    • What India can learn from China: Dictatorship, democracy and the road not taken
    • This book is an alternative account of literary beginnings in modern India through women’s writings
    • Bihar voter roll revision: Why having to prove you are an Indian citizen is a nightmare
    • Mount Everest: A new route avoids treacherous Khumbu Icefall in safer path to summit
    • National Herald case: Sonia, Rahul Gandhi aimed to usurp assets worth Rs 2,000 crore, ED tells court
    • Are our pampered pets really living their best life?
    • A beginner’s guide to weight-lifting in the gym
    • Review: Rekha is the life and soul of Muzaffar’s Ali’s classic ‘Umrao Jaan’
  • Sections
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Science and Technology
    • In Pictures
    • Announcements
    • Bookshop
    • The Field
    • Pulse
    • Elections 2024

US FDA

  • US FDA flags glaring lapses by Indian firm that made eye drops linked to vision loss and deaths

    US FDA flags glaring lapses by Indian firm that made eye drops linked to vision loss and deaths

    Tabassum Barnagarwala
    · Apr 04, 2023 · 03:00 pm
  • Covid: Pfizer says its antiviral pill cuts risk of hospitalisation, death by 89%

    Covid: Pfizer says its antiviral pill cuts risk of hospitalisation, death by 89%

    Scroll Staff
    · Nov 05, 2021 · 06:29 pm
  • Covid-19: Pfizer says its vaccine works for children aged 5 to 11, company to seek US approval soon

    Covid-19: Pfizer says its vaccine works for children aged 5 to 11, company to seek US approval soon

    Scroll Staff
    · Sep 20, 2021 · 06:11 pm
  • Coronavirus: US drug regulator rejects emergency use approval for Bharat Biotech’s Covaxin

    Coronavirus: US drug regulator rejects emergency use approval for Bharat Biotech’s Covaxin

    Scroll Staff
    · Jun 11, 2021 · 11:51 am
  • Coronavirus: Pfizer’s vaccine provides strong protection after first dose, says US drug regulator

    Coronavirus: Pfizer’s vaccine provides strong protection after first dose, says US drug regulator

    Scroll Staff
    · Dec 08, 2020 · 09:31 pm
  • US drug agency grants emergency use authorisation to antibody therapy given to Donald Trump

    US drug agency grants emergency use authorisation to antibody therapy given to Donald Trump

    Scroll Staff
    · Nov 22, 2020 · 08:58 am
  • Coronavirus: US approves first self-testing kit, results at home within 30 minutes

    Coronavirus: US approves first self-testing kit, results at home within 30 minutes

    Scroll Staff
    · Nov 18, 2020 · 01:36 pm
  • Covid-19: US FDA withdraws emergency use authorisation for hydroxychloroquine, chloroquine

    Covid-19: US FDA withdraws emergency use authorisation for hydroxychloroquine, chloroquine

    Scroll Staff
    · Jun 15, 2020 · 10:55 pm
  • Indian pharmaceutical firm recalls drug from US after investigation into cancer-causing element

    Indian pharmaceutical firm recalls drug from US after investigation into cancer-causing element

    Scroll Staff
    · Aug 11, 2018 · 06:35 pm
  • Indian pharmaceutical firm recalls drug from US after investigation into cancer-causing element

    Indian pharmaceutical firm recalls drug from US after investigation into cancer-causing element

    Scroll Staff
    · Aug 11, 2018 · 05:35 pm
  • India’s largest drugmaker gets a warning letter from US FDA

    India’s largest drugmaker gets a warning letter from US FDA

    Scroll Staff
    · Dec 20, 2015 · 02:13 pm